A CRISPR/Cas9 genome editing pipeline in the EndoC-βH1 cell line to study genes implicated in beta cell function (Wellcome Open Research, 2019)

(untitled) - Grotz, A; Abaitua, F; Navarro-Guerrero, E; Hastoy, B; Ebner, D; Gloyn, A